MULTIPLE MYELOMA COMPREHENSIVE PROFILE
This profile helps to track the progression of Myeloma and the response to treatment. Detection of minimal residual disease in Multiple Myeloma predicts outcome, helps identify impending relapse and enables early intervention, better post transplant surveillance and better clinical management of patients.
Parameter(s) covered : 50
Report Frequency: Sample Daily by 9 am; Report 3 Working days
Special Instruction: Overnight fasting preferred. Following information is mandatory:
Sample time point (Chemotherapy time points); Previous diagnostic immunophenotype report; Clinical History to include if patient is on anti-CD38 therapy; Original TRF; Date and time when sample was drawn.
Price : ₹ 16200.00
Parameters
- A : G Ratio
- Albumin
- Albumin Serum
- Alpha 1 globulin
- Alpha 2 globulin
- AUTOSUM
- Bands Forms
- Basophils
- Beta 1 globulin
- Beta 2 globulin
- Beta-2 Microglobulin, Serum
- Blasts
- Calcium, Total
- Creatinine
- Eosinophils
- Gamma globulin
- GFR Category
- GFR Estimated
- Hemoglobin
- IgA
- IgM
- Immunofixation Electrophoresis
- Immunogloublin IgG, Serum
- Instrument
- Kappa, Free Light Chain
- Kappa/Lambda(FLC), Ratio
- Lambda, Free Light Chain
- LDH
- Lymphocytes
- M Spike
- MCH
- MCHC
- MCV
- Mean Platelet Volume
- Metamyelocytes
- Monocytes
- MPV (Mean Platelet Volume)
- Myelocytes
- Neutrophils
- Others
- Packed Cell Volume (PCV)
- Platelet Count
- Promyelocytes
- Protein, Total
- RBC Count
- Red Cell Distribution Width (RDW)
- Segmented Neutrophils
- Software
- Total Leukocyte Count (TLC)
- Urea